Alimera Sciences, Inc. (NASDAQ: ALIM) (“Alimera”), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Our lead product is ILUVIEN, now approved for marketing in the U...

Education

Pharmaceutical

Alimera Sciences

Rick Eiswirth

Kapil Kumar

Tom Sinnamon

Bryce Werner

Ben Flagler

Sergei Donskihh

Deirdre O Reilly

Catherine Griffiths

Diane Reeves

Liz Michael

Kotaro Sai

David Gregory

Bill Garner

Trey Kincaid

Steve Morris

Riz Siddiqi

Mike Padilla

Larry Karner

Brittany Underhill

Benjamin Simon

Laura Cegala Sphr, Gphr

Christopher Visick

Steve Gill

David Dyer

Russell Skibsted

David Holland

Sales and Marketing

Medical Affairs

Leadership Team

Clinical Operations and Research

Teams at Alimera Sciences

Sales and Marketing

Medical Affairs

Leadership Team

Clinical Operations and Research